Skip to main content

Licensing of pharmaceutical representatives (SB 763) RAC

The Department of Consumer and Business Services (DCBS) is preparing to begin rulemaking on the licensing of pharmaceutical representatives specifically for SB 763 enacted during the 2021 Legislative Session. This bill provides that a person may not engage in business as pharmaceutical representative without obtaining a license from the director of DCBS.

Temporary Rules for Pharmaceutical Sales Representative Licensing.

All meetings held via Microsoft Teams meetings.
Join on your computer or mobile app.*
*Download the Microsoft Teams app

Scheduled meetings:

Tues. Jan. 18, 2022

Time: 2:00 – 3:30 p.m.
Click here to join the meeting
Or call in (audio only)
+1 503-446-4951,,252779304#
(United States, Portland)
Conference ID: 252 779 304#


Tues. Oct. 5, 2021

Meeting video

Documents:

Tues. Oct. 26, 2021

Meeting video

Documents:

Tues. Nov. 16, 2021

Meeting video

Committee:

Anne Murray
Bristol-Myers-Squibb

Asher Lisec
PhRMA

Brian Van Hoy
G&M Health, LLC

Chloe Becker
OCAP

Jen Baker
Providence

Maribeth Buarino
OSPIRG

Mark Bonanno
Oregon Medical Association

Rick Blackwell
PacificSource

Public Meetings:

Advisory committee meetings are open to the public. Public comments are allowed at the end of each RAC meeting. Due to time limitations and to ensure that public comments are correctly recorded, individuals are strongly encouraged to submit public comments in writing via email to DFR.rules@oregon.gov

Committee Contacts:

Numi Lee Griffith
Senior Policy Adviser
Division of Financial Regulation
Numi.L.Griffith@dcbs.oregon.gov
Phone: 503-428-4723

Karen Winkel
Rules Coordinator
Division of Financial Regulation
Karen.J.Winkel@dcbs.oregon.gov
Phone: 503-947-7694

Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how

×